Resources for Food and Drug Administration (FDA)

FDA extends comment period on cephalosporin restrictions

www.avma.org

The Food and Drug Administration has extended the comment period on a final rule to prohibit extralabel uses of cephalosporins in food animals.

According to the rule, the FDA decided on the prohibition because of information supporting the agency's conclusion that extralabel uses of the cephalosporin class of antimicrobial drugs are likely contributing to the emergence of cephalosporin-resistant foodborne pathogens.Various parties asked the FDA to extend the comment period so they could examine the available evidence, consider the impact of the ruling, and provide constructive comment. The agency granted an additional 60 days, extending the comment period to Nov. 1 and delaying the effective date of the final rule to Nov. 30.

View the Resource

Share or bookmarklet this web page at: